Scholarlink

Background <p>In a real-world setting, the impact of below-the-knee (BTK) runoff status on outcomes following drug-coated balloon (DCB) treatment for femoropopliteal (FP) lesions remains insufficiently studied, and robust evidence is still lacking.</p> Methods <p>Between 2021 and 2024, a total of 1,574 patients undergoing drug-coated balloon (DCB) treatment for femoropopliteal arterial occlusive disease were retrospectively identified from 9 centers in China. Propensity score matching was applied to minimize baseline imbalances, resulting in 155 matched pairs for subsequent analysis. Outcome measures included 12-month amputation-free survival (AFS), freedom from clinically driven target lesion revascularization (CD-TLR), all-cause mortality, major adverse event rate, and amputation rate. Predictors of 12-month AFS were also analyzed.</p> Results <p>The mean age was 69.82 ± 9.16 years, and 78.06% of patients were male. Hypertension (71.61%), diabetes mellitus (65.48%), and hyperlipidemia (27.10%) were the predominant comorbid conditions observed in the study population. The incidence of coronary artery disease and chronic kidney disease (CKD) was 22.58% and 17.10%, respectively. The mean lesion length was 19.12 ± 11.19&#xa0;cm, with 56.77% being chronic total occlusions. Kaplan-Meier analysis revealed that the 12-month AFS was 93.67% in the group with 2–3 patent BTK arteries versus 84.93% in the group with 1 patent BTK artery, a statistically significant difference (log-rank test <i>P</i> = 0.028).</p> <p>In the overall cohort, univariable analysis indicated that renal insufficiency, chronic limb-threatening ischemia (CLTI), lesion length, concomitant BTK intervention, and preprocedural BTK runoff status were significantly associated with AFS. In the multivariable model, renal insufficiency, CLTI, and preprocedural BTK runoff status remained independent predictors of AFS.</p> Conclusion <p>In this multicenter real-world study, preprocedural BTK runoff status was associated with amputation-free survival after DCB treatment for femoropopliteal lesions. Compared with patients with a single patent BTK vessel, those with two or three patent BTK runoff vessels showed a lower event risk across different clinical and anatomical subgroups. These findings suggest that preprocedural BTK runoff status may serve as an important reference for risk stratification and prognostic assessment after DCB treatment.</p> Trial registration <p>ClinicalTrials.gov, NCT04826705.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of below-the-knee runoff in patients undergoing drug-coated balloon angioplasty for femoropopliteal disease: a propensity score-matched analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月8日

查看全文
  • Chunbo Li,
  • Youpeng Zhu,
  • Wenbo Yang,
  • Ye Du,
  • Qiong Song,
  • Tingyu Wang,
  • Xinyuan Wang,
  • Leixin Li,
  • Zibo Feng

摘要

Background

In a real-world setting, the impact of below-the-knee (BTK) runoff status on outcomes following drug-coated balloon (DCB) treatment for femoropopliteal (FP) lesions remains insufficiently studied, and robust evidence is still lacking.

Methods

Between 2021 and 2024, a total of 1,574 patients undergoing drug-coated balloon (DCB) treatment for femoropopliteal arterial occlusive disease were retrospectively identified from 9 centers in China. Propensity score matching was applied to minimize baseline imbalances, resulting in 155 matched pairs for subsequent analysis. Outcome measures included 12-month amputation-free survival (AFS), freedom from clinically driven target lesion revascularization (CD-TLR), all-cause mortality, major adverse event rate, and amputation rate. Predictors of 12-month AFS were also analyzed.

Results

The mean age was 69.82 ± 9.16 years, and 78.06% of patients were male. Hypertension (71.61%), diabetes mellitus (65.48%), and hyperlipidemia (27.10%) were the predominant comorbid conditions observed in the study population. The incidence of coronary artery disease and chronic kidney disease (CKD) was 22.58% and 17.10%, respectively. The mean lesion length was 19.12 ± 11.19 cm, with 56.77% being chronic total occlusions. Kaplan-Meier analysis revealed that the 12-month AFS was 93.67% in the group with 2–3 patent BTK arteries versus 84.93% in the group with 1 patent BTK artery, a statistically significant difference (log-rank test P = 0.028).

In the overall cohort, univariable analysis indicated that renal insufficiency, chronic limb-threatening ischemia (CLTI), lesion length, concomitant BTK intervention, and preprocedural BTK runoff status were significantly associated with AFS. In the multivariable model, renal insufficiency, CLTI, and preprocedural BTK runoff status remained independent predictors of AFS.

Conclusion

In this multicenter real-world study, preprocedural BTK runoff status was associated with amputation-free survival after DCB treatment for femoropopliteal lesions. Compared with patients with a single patent BTK vessel, those with two or three patent BTK runoff vessels showed a lower event risk across different clinical and anatomical subgroups. These findings suggest that preprocedural BTK runoff status may serve as an important reference for risk stratification and prognostic assessment after DCB treatment.

Trial registration

ClinicalTrials.gov, NCT04826705.